On the public citation graph

https://doi.org/10.2139/ssrn.4584775

0 signed · 12 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.autrev.2016.01.007openalex-extracted
Systemic sclerosis: An update in 2016
inferredcites →https://doi.org/10.1016/j.clim.2011.03.003openalex-extracted
IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice
inferredcites →https://doi.org/10.1016/j.jbspin.2015.06.017openalex-extracted
Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study
inferredcites →https://doi.org/10.1038/nrendo.2013.131openalex-extracted
Type 2 diabetes mellitus—an autoimmune disease?
inferredcites →https://doi.org/10.1055/s-2005-872851openalex-extracted
Association of Interleukin-6, C-reactive Protein, Interleukin-10 and Adiponectin Plasma Concentrations with Measures of Obesity, Insulin Sensitivity and Glucose Metabolism
inferredcites →https://doi.org/10.1080/09629350310001633379openalex-extracted
Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement
inferredcites →https://doi.org/10.1093/qjmed/hcz112openalex-extracted
Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sjögren syndrome
inferredcites →https://doi.org/10.1159/000513659openalex-extracted
The Rationale and Evidence for SGLT2 Inhibitors as a Treatment for Nondiabetic Glomerular Disease
inferredcites →https://doi.org/10.2337/dc10-1756openalex-extracted
Additional Autoimmune Disease Found in 33% of Patients at Type 1 Diabetes Onset
inferredcites →https://doi.org/10.2353/ajpath.2009.080574openalex-extracted
Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
inferredcites →https://doi.org/10.3390/ijms21176275openalex-extracted
Pathophysiology of Type 2 Diabetes Mellitus

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1177/09733698251366766openalex-snapshot
Increased Prevalence of Comorbidities in Systemic Sclerosis Patients in India
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.